WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan

WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :

It is better to invest in a fund with a longer track record as WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

The process for redemption is

• Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
• You will get information about the redemption and the NAV at which redeemed.
• The amount will be deposited in the designated bank account.

The AUM of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is currently ₹271 Crores.

The Top three stocks are Sun Pharma Inds., Cipla and Max Healthcare Inst and account for 26% of its portfolio. Top 5 and 10 stocks of fund account for 39% and 55% of fund’s portfolio respectively.

Top three sectors of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan fund are Healthcare, Others and Chemicals accounting for 99% of the total portfolio.

Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.

Ramesh Mantri and Dheeresh Pathak manage the WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan Fund.

WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan current PE ratio is 55.39 and PB ratio is 7.86

The asset allocation of WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is Stocks : 92.64%, Debt : 7.35% and Gold : 0%

The minimum SIP amount for WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹500.00

The exit load for WhiteOak Capital Pharma and Healthcare Fund - Growth - Direct Plan is 1% on or before 1 months, Nil after 1 months